Merck announces new biopharma heads for North America and China
Gary Zieziula to head biopharma business in North America and Marc Horn to lead biopharma business in China.
Merck has announced two appointments in two regions important for its biopharma business. Gary Zieziula will lead Merck’s biopharma business in North America and Marc Horn will take the helm of the biopharma business in China.
Gary Zieziula (61) has been appointed President and Managing Director of the biopharma business in the US and Canada, based in Rockland, Massachusetts, US, with immediate effect. In his role, he will be responsible for all areas of the company’s business including driving overall strategic direction and maximizing growth across the region.
Zieziula joined Merck in 2014 as Chief Commercial Officer in the US, having spent more than 30 years in the pharmaceutical industry, including senior level positions at MSD, Bristol Myers-Squibb, Roche and Amag Pharmaceuticals. Zieziula holds a Bachelor of Science degree from the State University of New York at Buffalo and an MBA from Canisius College.
“As we look to grow our biopharma business in North America, including our progress in oncology and immuno-oncology, Gary’s vision, experience and customer-centric approach are critical to lead the company forward,” said Simon Sturge, Chief Operating Officer at the Healthcare business of Merck, whom Zieziula will report to Zieziula’s predecessor, Paris Panayiotopoulos, accepted a new position outside of Merck at the end of last year.
In the first 9 months of 2015 net sales of Merck in North America amounted to € 1.9 billion, thereby accounting for 20% of Group sales. Healthcare sales in this region totalled € 1.1 billion in the first 9 months of 2015. In the first 9 months of 2015 Healthcare sales in North America represented two-thirds of Merck’s total sales in the region.
Marc Horn (41) will head the biopharma business of Merck in China as of 1 April 2016, as a Managing Director based in Beijing. He is currently the regional Chief Financial Officer of Merck responsible for Eastern Asia, comprising China, Hong Kong, Japan, South Korea and Taiwan, for the three business sectors Healthcare, Life Science and Performance Materials.
Horn has more than 16 years of management experience in finance in the pharmaceuticals and chemicals industry, including positions at Bayer and Lanxess in Germany, China and Singapore. Horn graduated from Otto-Friedrich University of Bamberg, Germany, and University of Maastricht, Netherlands, with a Master’s degree in International Business Administration.
Allan Gabor, Mark Horn’s predecessor, has been promoted to President of the AsianPacific region for Merck’s biopharma business. In his new position, Horn will report to Gabor.
China is of importance to Merck currently and in future. Among others the company is building a €80 million (650 million Yuan) pharmaceutical manufacturing plant in the Nantong Economical Technological Development Area (NETDA), in the Greater Shanghai region (Yangtze River Delta area). Completion of the facility, which will focus on bulk production and packaging of Glucophage, Concor and Euthyrox, is scheduled for 2016, with commercial production starting in 2017.
With an organic increase of 5.1%, sales in the Asia-Pacific region, where China is included, amounted to €3.1 billion in the months January to September 2015.
Representing a share of 33% of Group net sales, Asia-Pacific therefore became the Group’s top-selling region. Healthcare sales from January to September 2015 in the Asia-Pacific region reached around €1 billion, representing one-third of group sales in this region.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance